FOLFOX 6
Showing 26 - 50 of >10,000
Metastatic Pancreatic Cancer Trial in Washington (ABT-888 and mFOLFOX-6)
Unknown status
- Metastatic Pancreatic Cancer
- ABT-888 and mFOLFOX-6
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Mar 2, 2020
Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)
Completed
- Pancreatic Cancer Metastatic
-
Gainesville, FloridaUF Health Cancer Center
Dec 3, 2020
Rectal Cancer Trial in Guangzhou (mFOLFOX6, Radiotherapy)
Unknown status
- Rectal Cancer
- mFOLFOX6
- Radiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yatsen University
Apr 30, 2020
Colorectal Cancer Trial in Leeds, London, Cardiff (FOLFOX regimen, capecitabine, fluorouracil)
Completed
- Colorectal Cancer
- FOLFOX regimen
- +5 more
-
Leeds, England, United Kingdom
- +3 more
Sep 21, 2021
Colonic Cancer, Unresectable Metastasis Originating in Colonic Cancer Trial in Spain (Colonic resection, Chemotherapy- scheme)
Terminated
- Colonic Cancer
- Unresectable Metastasis Originating in Colonic Cancer
- Colonic resection
- Chemotherapy- scheme
-
Vitoria/Gasteiz, Araba, Spain
- +21 more
Mar 12, 2021
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)
Recruiting
- Locally Advanced Colorectal Carcinoma
- Cadonilimab
- FOLFOX regimen
-
Beijing, Beijing, ChinaCancer Hospital/ National Cancer Center, Chinese Academy of Medi
Nov 23, 2023
Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastric
Completed
- Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
- +5 more
- S-1 de-escalation
- Chemotherapy by Investigator's choice
-
Heidelberg, Baden-Württemberg, GermanyNCT-Med. Onkologie
Mar 25, 2021
Colorectal Cancer Trial in Spain (FOLFIRI (m), FOLFOX-6 (m), Cetuximab)
Completed
- Colorectal Cancer
- FOLFIRI (m)
- +2 more
-
Castelló de la Plana, Castellón, Spain
- +26 more
Jun 11, 2021
Gastroesophageal Adenocarcinoma Trial (toripalimab FOLFOX)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- toripalimab FOLFOX
- (no location specified)
Aug 3, 2023
Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)
Not yet recruiting
- Neuropathy;Peripheral
- Placebo tablets
- Ketotifen Oral Tablet
-
Tanta, EgyptTanta university
Nov 23, 2022
Microsatellite-stable Colorectal Cancer Trial (Standard of Care - mFOLFOX6, E1 - mFOLFOX and durvalumab, E2 - mFOLFOX6,
Withdrawn
- Microsatellite-stable Colorectal Cancer
- Standard of Care - mFOLFOX6
- +3 more
- (no location specified)
Sep 17, 2020
Esophageal Cancer Trial in San Francisco (Erlotinib, 5-fluorouracil, Leucovorin)
Terminated
- Esophageal Cancer
- Erlotinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 5, 2020
Chemo, Colorectal Cancer, Intestinal Mucositis Trial (Losartan 50mg Tab)
Not yet recruiting
- Chemotherapy
- +3 more
- Losartan 50mg Tab
- (no location specified)
May 13, 2023
Colon Cancer Trial (mFOLFIRINOX-FOLFIRI intensified chemo, FOLFOX or CAPOX adjuvant chemo)
Not yet recruiting
- Colon Cancer
- mFOLFIRINOX-FOLFIRI intensified chemotherapy
- FOLFOX or CAPOX adjuvant chemotherapy
- (no location specified)
Sep 6, 2022
Colon Cancer, Rectal Cancer Trial in Pawtucket, Providence (drug, radiation, procedure)
Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)
Recruiting
- Unresectable or Metastatic Colorectal Cancer
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Mar 22, 2023
Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)
Not yet recruiting
- Potentially Resectable Hepatocellular Carcinoma
- (no location specified)
Nov 16, 2023
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Adenocarcinoma of the Stomach, GastroEsophageal Cancer Trial in Germany (Nivolumab, Ipilimumab, mFOLFOX)
Active, not recruiting
- Adenocarcinoma of the Stomach
- GastroEsophageal Cancer
- Nivolumab
- +3 more
-
Amberg, Germany
- +26 more
Jan 12, 2023
Cancer, Gastro-Intestinal Intraepithelial Neoplasia Trial in Jerusalem (Promitil)
Active, not recruiting
- Cancer
- Gastro-Intestinal Intraepithelial Neoplasia
-
Jerusalem, IsraelShaare Zedek Medical Center
Dec 21, 2022